methylprednisolone has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, SG; Gribben, JG; Renaudon-Smith, E | 1 |
1 other study(ies) available for methylprednisolone and Leukemia, Lymphocytic, Chronic, T Cell
| Article | Year |
|---|---|
Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia, Prolymphocytic, T-Cell; Male; Methylprednisolone; Middle Aged; Treatment Outcome | 2014 |